COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 414
one autoimmune disease significantly increases the risk of
developing additional autoimmune conditions [15].
Early Intervention Opportunity
By identifying autoimmune reactivity in its earliest stages, Array 5
creates a critical window for preventive intervention. Research
suggests that addressing underlying triggers and modulating
immune function during this predictive antibody phase offers the
greatest potential for preventing or minimizing disease progression
[16].
Monitoring Treatment Efficacy
For patients already implementing interventions for autoimmune
risk, Array 5 can be used to monitor the effectiveness of these
approaches by tracking changes in antibody levels over time.
Decreasing antibody titers often correlate with improved clinical
outcomes [17].
Who Should Consider Array 5
Array 5 testing is particularly valuable for several patient
populations:
Family History of Autoimmunity
Individuals with a first-degree relative (parent, sibling, child) with
an autoimmune disease have a significantly increased risk of
developing autoimmunity themselves. This familial risk crosses
autoimmune conditions4for example, having a parent with
rheumatoid arthritis increases the risk not only for RA but for other
autoimmune conditions as well [18].
Early Symptoms Without Diagnosis
Many patients experience vague, non-specific symptoms for years
before receiving an autoimmune diagnosis. These symptoms often
414
